CCL11 and Alzheimer disease: Our findings of elevated eotaxin immunoreactivity in the MCI/AD serum corresponds with previous reports showing its increased levels in the serum and CSF of humans with neurodegenerative diseases, including AD [26,32], and in the serum of aged patients with neuropsychiatric symptoms [31].